Ovarian cancers are still largely treated with platinum-based chemotherapy as the standard of care, yet few biomarkers of clinical response have had an impact on clinical decision making. Previous ...

Breast cancer is the second leading cause of cancer mortality in women with an estimated number of 42,250 deaths and 310,720 new cases in 2024 in the United States 1. Although breakthroughs in cancer ...

Researchers at the University of Arizona R. Ken Coit College of Pharmacy have developed a new strategy that helps the immune ...

Genome-wide maps of chromatin structure in a cell-based model of breast cancer reveal chromatin reorganization accompanied by changes in transcription and epigenetic marks.